Software that enables Apple Watch-based tracking of Parkinson’s disease symptoms has received clearance from the Food and Drug Administration, a move that could open doors for its maker as it strives to reach more people living with movement disorders — and potentially, those who haven’t developed them yet.
The StrivePD system uses Apple’s Movement Disorder API to track tremors and dyskinetic symptoms of Parkinson’s from the Apple Watch. The data is all collected in an iPhone application, which allows patients to record their symptoms and keep tabs on medication.
StrivePD was developed by Rune Labs, a neurological data startup run by Brian Pepin, a former engineer from Alphabet life science company Verily. The company announced last year that it had raised nearly $23 million to continue to develop its neurology data platform. Also last year, the company launched a partnership with Medtronic to pilot data collection from the company’s Percept PC Deep Brain Stimulation device. The StrivePD platform can integrate data from these devices, making it a kind of one-stop shop for clinicians and clinical trial sponsors who want to review data.
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect